` DNA (Ginkgo Bioworks Holdings Inc) vs 4063 (Shin-Etsu Chemical Co Ltd) Comparison - Alpha Spread

DNA
vs
4063

Over the past 12 months, DNA has underperformed Shin-Etsu Chemical Co Ltd, delivering a return of +9% compared to the Shin-Etsu Chemical Co Ltd's +83% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
DNA
4063
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

DNA Intrinsic Value
LOCKED
Unlock
Shin-Etsu Chemical Co Ltd Intrinsic Value
LOCKED
Unlock
Company Last Price Intrinsic Value DCF Value Multiples-Based Value Wall St Target
Ginkgo Bioworks Holdings Inc
NYSE:DNA
8.03 USD
Shin-Etsu Chemical Co Ltd
TSE:4063
6 907 JPY
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
DNA, 4063

DNA
4063
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Ginkgo Bioworks Holdings Inc
Revenue
Shin-Etsu Chemical Co Ltd
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
DNA, 4063

DNA
4063
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Ginkgo Bioworks Holdings Inc
NYSE:DNA
Shin-Etsu Chemical Co Ltd
TSE:4063
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

DNA
72.4%
Shin-Etsu Chemical Co Ltd
35.2%

Operating Margin

DNA
-182.1%
Shin-Etsu Chemical Co Ltd
25%

Net Margin

DNA
-183.8%
Shin-Etsu Chemical Co Ltd
18.9%

FCF Margin

DNA
-105%
Shin-Etsu Chemical Co Ltd
14.7%

ROE

DNA
-51.1%
Shin-Etsu Chemical Co Ltd
11.1%

ROA

DNA
-25.1%
Shin-Etsu Chemical Co Ltd
9%

ROIC

DNA
-41.5%
Shin-Etsu Chemical Co Ltd
12.5%

ROCE

DNA
-27%
Shin-Etsu Chemical Co Ltd
13.1%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
DNA, 4063

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
DNA, 4063

Performance Gap Between DNA and 4063
LOCKED
Unlock

Performance By Year
DNA, 4063

Loading
DNA
4063
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare DNA to other stocks
SHW
Sherwin-Williams Co
Cheaper
vs DNA
ECL
Ecolab Inc
Cheaper
vs DNA
4957
Yasuhara Chemical Co Ltd
Y
Cheaper
vs DNA
600309
Wanhua Chemical Group Co Ltd
More expensive
vs DNA
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett